Donât get too carried away..11 Oct 2025 11:20
Whilst we are all optimistic, to different degrees, of deal(s) coming in the next 3-12 months, we also need to keep balance.
Please consider :
- Tims last interview âdo I think we are overvalued, no I donâtâ. Now that is not a reply youâd expect if he thought it had 10 times more to go.
- NAV at beginning of year was negative ÂŁ500,000. Yep no asset value.
- Market cap today is ÂŁ55m, hence deals are already priced in.
- They have yet to have patent granted which could take 2 years.
- They have yet to start P3 trials which will also take 2 years.
- Tim has been a little bit overzealous which is obvious.
- There has been zero institutional investment so we are not on the radars of key investors, why?
Highly possible that a large Pharma will take a punt on what they see from their due diligence, many do. But it is an early stage asset and it wont be able to command some of the nonsense valuations people are suggesting. I stand by my hope of a deal in H1 2026 leading to a share price of 20-30p.